This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, W.
Right arrow Articles by Malcolm, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, W.
Right arrow Articles by Malcolm, B. A.

 Previous Article  |  Next Article 

Journal of Virology, January 2004, p. 700-709, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.700-709.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Conserved C-Terminal Threonine of Hepatitis C Virus NS3 Regulates Autoproteolysis and Prevents Product Inhibition

Wenyan Wang,1,{dagger} Frederick C. Lahser,2,{dagger} MinKyung Yi,3 Jacquelyn Wright-Minogue,2 Ellen Xia,2 Patricia C. Weber,1 Stanley M. Lemon,3 and Bruce A. Malcolm2*

Departments of Structural Chemistry,1 Antiviral Therapeutics, Schering-Plough Research Institute, Kenilworth, New Jersey 07033,2 Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas 775513

Received 9 June 2003/ Accepted 2 October 2003

Inspection of over 250 hepatitis C virus (HCV) genome sequences shows that a threonine is strictly conserved at the P1 position in the NS3-NS4A (NS3-4A) autoproteolysis junction, while a cysteine is maintained as the P1 residue in all of the putative trans cleavage sites (NS4A-4B, NS4B-5A, and NS5A-5B). To understand why T631 is conserved at the NS3-4A junction of HCV, a series of in vitro transcription-translation studies were carried out using wild-type and mutant (T631C) NS3-4A constructs bearing native, truncated, and mutant NS4A segments. The autocleavage of the wild-type junction was found to be dependent on the presence of the central cofactor domain of NS4A (residues 21 to 34). In contrast, all NS3-4A T631C mutant proteins underwent self-cleavage even in the absence of the cofactor. Subgenomic replicons derived from the Con1 strain of HCV and bearing the T631C mutation showed reduced levels of colony formation in transfection studies. Similarly, replicons derived from a second genotype 1b virus, HCV-N, demonstrated a comparable reduction in replication efficiency in transient-transfection assays. These data suggest that the threonine is conserved at position 631 because it serves two functions: (i) to slow processing at the NS3-4A cleavage site, ensuring proper intercalation of the NS4A cofactor with NS3 prior to polyprotein scission, and (ii) to prevent subsequent product inhibition by the NS3 C terminus.


* Corresponding author. Mailing address: Department of Antiviral Therapeutics, K-15-4945, Schering-Plough Research Institute, 2015 Galloping Hill Rd., Kenilworth, NJ 07033. Phone: (908) 740-6738. Fax: (908) 740-3918. E-mail: bruce.malcolm{at}spcorp.com.

{dagger} W.W. and F.C.L. contributed equally to this work.


Journal of Virology, January 2004, p. 700-709, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.700-709.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Beran, R. K. F., Pyle, A. M. (2008). Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase. J. Biol. Chem. 283: 29929-29937 [Abstract] [Full Text]  
  • Lin, M. Z., Glenn, J. S., Tsien, R. Y. (2008). From the Cover: A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals. Proc. Natl. Acad. Sci. USA 105: 7744-7749 [Abstract] [Full Text]  
  • Yi, M., Tong, X., Skelton, A., Chase, R., Chen, T., Prongay, A., Bogen, S. L., Saksena, A. K., Njoroge, F. G., Veselenak, R. L., Pyles, R. B., Bourne, N., Malcolm, B. A., Lemon, S. M. (2006). Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor: REDUCED RNA REPLICATION FITNESS AND PARTIAL RESCUE BY SECOND-SITE MUTATIONS. J. Biol. Chem. 281: 8205-8215 [Abstract] [Full Text]  
  • Breiman, A., Grandvaux, N., Lin, R., Ottone, C., Akira, S., Yoneyama, M., Fujita, T., Hiscott, J., Meurs, E. F. (2005). Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKK{varepsilon}. J. Virol. 79: 3969-3978 [Abstract] [Full Text]